A major discovery in cancer study is emerging with the use of mini-antibodies to re-engage mutated p53. This essential tumor protector protein is frequently disabled in many kinds of cancer, resulting uncontrolled https://webnowmedia.com/story7433187/nanobodies-revive-the-p53-protein-the-promising-approach-for-cancer-treatment